NHMAF(NHMAF)
NHMAF
$4.14—Stale · unknown old
OTC • Last print unknown ago
$4.14—Stale · unknown old
No analyst ratings available
No analyst price targets available for NHMAF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $56.02B | $60.91B | $66.21B | $59.97B | $62.21B |
| Low | $53.02B | $55.44B | $61.42B | $55.63B | $57.71B |
| High | $57.40B | $63.16B | $68.27B | $61.83B | $64.15B |
| EBITDA Avg | $21.79B | $23.48B | $25.89B | $22.76B | $23.42B |
| Low | $19.76B | $21.29B | $23.47B | $20.65B | $21.24B |
| High | $22.67B | $24.42B | $26.92B | $23.67B | $24.36B |
| EBIT Avg | $21.59B | $23.25B | $25.65B | $22.52B | $23.16B |
| Low | $19.56B | $21.06B | $23.23B | $20.40B | $20.98B |
| High | $22.46B | $24.19B | $26.68B | $23.43B | $24.10B |
| Net Income Avg | $14.12B | $15.21B | $16.78B | $14.73B | $15.15B |
| Low | $12.79B | $13.78B | $15.20B | $13.34B | $13.72B |
| High | $14.69B | $15.83B | $17.45B | $15.32B | $15.76B |
| EPS Avg | $44.50 | $47.94 | $52.87 | $46.42 | $47.75 |
| Low | $40.32 | $43.43 | $47.90 | $42.05 | $43.26 |
| High | $46.30 | $49.88 | $55.01 | $48.29 | $49.68 |
| Analysts (Rev / EPS) | 6 / 1 | 6 / 1 | 4 / 1 | 3 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $14.45B | $16.88B | $14.09B |
| Low | $13.39B | $15.79B | $13.12B |
| High | $15.45B | $17.60B | $14.86B |
| EBITDA Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EBIT Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 3 / — | 3 / — | 1 / — |